Vincerx Pharma, Inc. Earnings Per Share, Basic and Diluted
Vincerx Pharma, Inc. reported Earnings Per Share, Basic and Diluted of -$0.79 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Vincerx Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.79.
- Vincerx Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$309.95.
- Vincerx Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.39.
- Vincerx Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.12.
- Vincerx Pharma, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.29.
- Vincerx Pharma, Inc. earnings per share, basic and diluted for fiscal 2020 was -$3.16.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 10 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.79 10-Q · filed 2022-05-12 | -$1096.11 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2392.09 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2608.99 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||
| 2021-12-31 | -$309.95 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1607.05 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1804.10 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$2.29 10-K · filed 2022-03-29 | ||
| 2021-09-30 | -$1.39 10-Q · filed 2021-11-12 | -$1560.22 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.06 10-Q · filed 2021-11-12 | -$3655.85 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||
| 2021-06-30 | -$0.12 10-Q · filed 2021-08-12 | -$0.55 10-Q · filed 2021-08-12 | -$2046.62 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$2421.79 derived: net income ÷ weighted average shares · filed 2022-08-11 | ||
| 2021-03-31 | -$0.46 10-Q · filed 2022-05-12 | -$2290.82 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$2769.11 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$3075.43 derived: net income ÷ weighted average shares · filed 2022-05-12 | ||
| 2020-12-31 | -$2733.62 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$3006.89 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$3107.92 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$3.16 10-K · filed 2022-03-29 | -$2.04 10-K · filed 2021-03-22 | |
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-12 | -$67.43 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.07 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$0.01 10-Q · filed 2021-08-12 | -$0.01 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | -$0.01 10-K/A · filed 2021-05-14 |